Volume 32, Issue 21 (February 16, 2024)
For the full issue, subscribers click here.
Article
New US Lab Construction Leads to Oversupply
Executive Briefing
The latest on Bruker, Bio-Techne and more
Financial
Fourth Quarter Results: Bio-Techne, QIAGEN and Shimadzu
Market Profile
Organ-on-a-Chip
Industry Watch
Biopharma: Lab Transformation
Biotech: IPO Rebound
Government: Animal Testing Alternatives
Region Watch
EU: Horizon Europe’s Budget Cut
China: Solid-State Battery R&D
UK: 2022’s Health Research Funding
News
Life Science Consumables
Gene-Based Analysis
Cell-Based Analysis
Protein-Based Analysis
Sequencing
Spectroscopy
Informatics
Bottom Line
Companies’ latest financial results
< Previous Article | Next Article >